Hugel 'Bylizeun Skin Booster HA', "Average Wrinkle Severity Index Reduced by 40%"

Aesthetic specialist company Hugel announced on the 21st that its paper on ‘Bylizen Skin Booster HA’ has been accepted by the SCI-level international journal, the Journal of Cosmetic Dermatology.

Image of Hugel's 'Bylizen Skin Booster HA'
Photo by Hugel

This study evaluated the efficacy and safety of Bylizen Skin Booster HA in improving skin wrinkles and elasticity by administering three injections at two-week intervals to 20 adult men and women aged 30 to 60 with cheek wrinkles and decreased skin elasticity. The main evaluation indices included the improvement rate of the wrinkle severity index (Lemperle wrinkle scale) at 6, 8, and 12 weeks after administration, as well as skin roughness, elasticity, pores, moisture, gloss, overall appearance improvement, and safety. Conclusions were drawn based on results tracked for 12 weeks after injection.

According to the study results, the average wrinkle severity index decreased by 40% at 8 weeks after Bylizen Skin Booster HA administration and was maintained at about 33% until 12 weeks. Indicators such as wrinkle height, roughness, elasticity, pore size, moisture, and gloss showed statistically significant improvement, and no serious adverse events were reported.

This paper demonstrated that Bylizen Skin Booster HA generally improved wrinkles, elasticity, and pores over time after injection into the skin. It also proved that hyaluronic acid (HA)-based fillers are effective and safe treatment materials for improving skin quality.

A Hugel representative said, “With this acceptance in an international journal, we can prove the competitiveness of Bylizen Skin Booster HA,” adding, “We will actively expand our influence in the market by promoting the differentiated value of Bylizen Skin Booster HA through evidence-based marketing.”

This content was produced with the assistance of AI translation services.